304 related articles for article (PubMed ID: 28470586)
21. Nanotechnology and the transdermal route: A state of the art review and critical appraisal.
Cevc G; Vierl U
J Control Release; 2010 Feb; 141(3):277-99. PubMed ID: 19850095
[TBL] [Abstract][Full Text] [Related]
22. Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives.
Trimble J; Light B
Int J Pharm Compd; 2016; 20(3):250-256. PubMed ID: 28333667
[TBL] [Abstract][Full Text] [Related]
23. Delivering drugs by the transdermal route: review and comment.
Tanner T; Marks R
Skin Res Technol; 2008 Aug; 14(3):249-60. PubMed ID: 19159369
[TBL] [Abstract][Full Text] [Related]
24. Transdermal delivery of imipramine and doxepin from newly oil-in-water nanoemulsions for an analgesic and anti-allodynic activity: development, characterization and in vivo evaluation.
Sandig AG; Campmany AC; Campos FF; Villena MJ; Naveros BC
Colloids Surf B Biointerfaces; 2013 Mar; 103():558-65. PubMed ID: 23261580
[TBL] [Abstract][Full Text] [Related]
25. Transdermal delivery and the premature neonate.
Barrett DA; Rutter N
Crit Rev Ther Drug Carrier Syst; 1994; 11(1):1-30. PubMed ID: 7704917
[TBL] [Abstract][Full Text] [Related]
26. The transdermal delivery of fentanyl.
Lane ME
Eur J Pharm Biopharm; 2013 Aug; 84(3):449-55. PubMed ID: 23419814
[TBL] [Abstract][Full Text] [Related]
27. Use of transdermal drug formulations in the elderly.
Kaestli LZ; Wasilewski-Rasca AF; Bonnabry P; Vogt-Ferrier N
Drugs Aging; 2008; 25(4):269-80. PubMed ID: 18361538
[TBL] [Abstract][Full Text] [Related]
28. Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers.
Paudel KS; Hammell DC; Agu RU; Valiveti S; Stinchcomb AL
Drug Dev Ind Pharm; 2010 Sep; 36(9):1088-97. PubMed ID: 20545522
[TBL] [Abstract][Full Text] [Related]
29. Turning theory into practice: the development of modern transdermal drug delivery systems and future trends.
Perumal O; Murthy SN; Kalia YN
Skin Pharmacol Physiol; 2013; 26(4-6):331-42. PubMed ID: 23921120
[TBL] [Abstract][Full Text] [Related]
30. An integrated biophysical model for predicting the clinical pharmacokinetics of transdermally delivered compounds.
Somayaji MR; Das D; Garimella HT; German CL; Przekwas AJ; Simon L
Eur J Pharm Sci; 2021 Dec; 167():105924. PubMed ID: 34289340
[TBL] [Abstract][Full Text] [Related]
31. Advanced progress of microencapsulation technologies: in vivo and in vitro models for studying oral and transdermal drug deliveries.
Lam PL; Gambari R
J Control Release; 2014 Mar; 178():25-45. PubMed ID: 24417967
[TBL] [Abstract][Full Text] [Related]
32. Challenges and Future Prospects for the Delivery of Biologics: Oral Mucosal, Pulmonary, and Transdermal Routes.
Morales JO; Fathe KR; Brunaugh A; Ferrati S; Li S; Montenegro-Nicolini M; Mousavikhamene Z; McConville JT; Prausnitz MR; Smyth HDC
AAPS J; 2017 May; 19(3):652-668. PubMed ID: 28194704
[TBL] [Abstract][Full Text] [Related]
33. Enhancing Permeation of Drug Molecules Across the Skin via Delivery in Nanocarriers: Novel Strategies for Effective Transdermal Applications.
Yu YQ; Yang X; Wu XF; Fan YB
Front Bioeng Biotechnol; 2021; 9():646554. PubMed ID: 33855015
[TBL] [Abstract][Full Text] [Related]
34. Permeation enhancer strategies in transdermal drug delivery.
Marwah H; Garg T; Goyal AK; Rath G
Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
[TBL] [Abstract][Full Text] [Related]
35. Trends in nanotechnology-based delivery systems for dermal targeting of drugs: an enticing approach to offset psoriasis.
Saleem S; Iqubal MK; Garg S; Ali J; Baboota S
Expert Opin Drug Deliv; 2020 Jun; 17(6):817-838. PubMed ID: 32315216
[TBL] [Abstract][Full Text] [Related]
36. Ultrasound mediated transdermal drug delivery.
Azagury A; Khoury L; Enden G; Kost J
Adv Drug Deliv Rev; 2014 Jun; 72():127-43. PubMed ID: 24463344
[TBL] [Abstract][Full Text] [Related]
37. Targeted cutaneous delivery of ciclosporin A using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways.
Lapteva M; Santer V; Mondon K; Patmanidis I; Chiriano G; Scapozza L; Gurny R; Möller M; Kalia YN
J Control Release; 2014 Dec; 196():9-18. PubMed ID: 25278258
[TBL] [Abstract][Full Text] [Related]
38. Breaking boundaries: the advancements in transdermal delivery of antibiotics.
Zaid Alkilani A; Hamed R; Musleh B; Sharaire Z
Drug Deliv; 2024 Dec; 31(1):2304251. PubMed ID: 38241087
[TBL] [Abstract][Full Text] [Related]
39. Transdermal Drug Delivery: A Step towards Treatment of Cancer.
Kriplani P; Guarve K
Recent Pat Anticancer Drug Discov; 2022; 17(3):253-267. PubMed ID: 34856914
[TBL] [Abstract][Full Text] [Related]
40. An update on the application of physical technologies to enhance intradermal and transdermal drug delivery.
Herwadkar A; Banga AK
Ther Deliv; 2012 Mar; 3(3):339-55. PubMed ID: 22833994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
